ArticleJournal of hepatocellular carcinoma2025

Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors.

Wen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.